Want a glass of wine with dinner? Blame our ape ancestors
To better understand the relationship between humans and alcohol, researchers are studying the animals' fondness for fermented and fallen fruit, newly referred to as 'scrumping.'
"Scrumping by the last common ancestor of gorillas, chimpanzees, and humans about 10 million years ago could explain why humans are so astoundingly good at digesting alcohol," Nathaniel Dominy, the Charles Hansen Professor of Anthropology at Dartmouth College, said in a statement.
"We evolved to metabolize alcohol long before we ever figured out how to make it, and making it was one of the major drivers of the Neolithic Revolution that turned us from hunter-gatherers into farmers and changed the world,' he added.
Fermentation is the process by which bacteria and other microorganisms break down sugars into substances such as alcohols or acids. All of the alcohol we drink is made this way.
When you drink alcohol, you get drunk because you're consuming faster than your metabolism can handle. In apes, researchers said this doesn't seem to be the case.
Geneticists previously reported that eating fermented fruit may have led to a biological change in the last common ancestor of humans and African apes that boosted their ability to metabolize alcohol by 40 times.
However, no one had the data to test it, and scientists had not differentiated fruit in the trees from that on the ground when studying the primates since then.
"It just wasn't on our radar," Dominy explained. "It's not that primatologists have never seen scrumping — they observe it pretty regularly. But the absence of a word for it has disguised its importance.'
The team wanted to know what significance scrumping had for human evolution so analyzed previous research on dietary habits of orangutans, chimpanzees, and mountain and western gorillas in the wild.
The studies included thousands of scans of the primates eating fruit. If an ape at ground level was recorded eating fruit known to grow in the middle or upper levels of the forest canopy, it was counted as scrumping.
Of the three species, African apes were found to 'scrump' regularly, while orangutans did not. To better understand chimpanzees' alcohol consumption, the researchers will next measure the levels of fermentation in fruits in trees, versus that on the ground.
The researchers said their findings confirm results of past research which had also found that the primary enzyme for metabolizing ethanol — found in alcoholic beverages — is relatively inefficient in orangutans and other non-human primates.
The researchers believe that the African apes' ability to metabolize ethanol may let them safely consume a whopping 10 pounds of fruit each day.
That level of intake suggests exposure to ethanol could be a significant component of chimpanzee life, and a major force of human evolution. Humans may have retained the social aspects that apes bring to scrumping, Catherine Hobaiter, a professor of psychology and neuroscience at St Andrews, said.
"A fundamental feature of our relationship with alcohol is our tendency to drink together, whether a pint with friends or a large social feast," she added. "The next step is to investigate how shared feeding on fermented fruits might also influence social relationships in other apes."
Solve the daily Crossword
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
12 hours ago
- Medscape
Can Treating Siblings Aid Azithromycin's Effect on Infants?
TOPLINE: Mass administration of azithromycin to both infants aged 1-11 months and children aged 12-59 months reduced infant mortality compared with treating infants alone. Although the interaction effect was not statistically significant, mortality appeared to be lower among infants living with treated older siblings. METHODOLOGY: In this secondary analysis of a cluster-randomized trial, researchers evaluated whether mass azithromycin administration reduced infant mortality and examined how that benefit varied when an older sibling in the same household also received azithromycin. They included 98,969 infants aged 1-11 months with a minimum weight of 3 kg and no known macrolide allergies who received biannual 20-mg/kg doses of oral azithromycin or placebo from November 2020 to July 2023 in Niger. Participants were divided into three arms: infants and children aged 1-59 months on azithromycin (child arm), infants aged 1-11 months on azithromycin and children aged 12-59 months on placebo (infant arm), and children aged 1-59 months on placebo (placebo arm). The primary outcome was the community-level rate of all-cause mortality among infants aged 1-11 months after 2 years of azithromycin distribution, stratified by the presence or absence of older siblings (12-59 months) in the household. TAKEAWAY: The mortality rate of infants per 1000 person-years at risk was lowest in the child arm at 18.5 deaths (95% CI, 16.7-20.4) compared with 22.3 deaths (95% CI, 20.0-24.7) in the infant arm and 23.9 deaths (95% CI, 21.6-26.2) in the placebo arm. In communities receiving azithromycin vs placebo, mortality among infants aged 1-11 months declined by 23% (95% CI, 11%-33%). Of this reduction, 23.5% (95% CI, 1.2%-72.7%) was attributable to treating infants directly, while 76.5% (95% CI, 27.3%-98.8%) resulted from also treating children aged 12-59 months. Among infants with older siblings, the incidence rate ratio comparing child and infant arms was 0.78 (95% CI, 0.65-0.93), while it was 0.91 (95% CI, 0.73-1.15) for those without siblings (P for interaction = .26). IN PRACTICE: 'The main trial results support implementation of azithromycin MDA [mass drug administration] to infants and children aged 1-59 months to achieve the greatest benefit. The analyses presented herein further support this conclusion and suggest that the spillover mechanism may include treating older siblings,' the authors wrote. SOURCE: This study was led by Ahmed M. Arzika, MPH, Centre de Recherche et d'Intervention en Santé Publique, Birni N'Gaoure, Niger. It was published online on July 10, 2025, in JAMA Network Open. LIMITATIONS: Limited statistical power restricted the detection of interaction effects in subgroup analyses. Even in high ‐ mortality settings, deaths remain too infrequent to reveal significant differences between subgroups. The large simple trial design prevented the evaluation of cause-specific mortality. Thus, analysis of specific causes of death likely associated with spillover effects of the mass administration of azithromycin could not be determined. DISCLOSURES: This study received support from the Bill & Melinda Gates Foundation and National Institute of Allergy and Infectious Diseases of the National Institutes of Health. Pfizer Inc donated the azithromycin and placebo used in the trial. A few authors reported receiving grants from the funding organization. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Medscape
14 hours ago
- Medscape
ART-Treated Children Remain at Risk for Vascular Disease
Children born with HIV and treated early with antiretroviral therapy (ART) continued to show elevated immune markers in adolescence, based on data presented at the International AIDS Society Conference on HIV Science. Although universal early ART has improved long-term health outcomes for children with perinatal HIV, data on long-term effects of ART exposure are limited, wrote Claire Davies, PhD, a researcher at Stellenbosch University, Cape Town, South Africa, and colleagues. 'Prior to 2008-2009, antiretroviral therapy for children living with perinatal HIV was withheld until HIV disease was advanced,' Davies said in an interview. 'The reasoning was that ART, having been developed from cancer chemotherapy, had significant toxicity and it was thought best to spare infants from those toxicities until benefit clearly outweighed risk,' she said. In 2009, the landmark CHER trial showed that apparently well infants living with HIV who were given empiric ART soon after birth had approximately 400% better survival compared with those with no intervention. 'Immediate worldwide implementation of this intervention has led to emergence of an entirely new disease profile: Since 2009, early initiation of ART has been standard-of-care for perinatally-infected infants,' Davies told Medscape Medical News . 'Since early-treated children living with HIV [CHIV] would then be spared from repeated opportunistic infections and years of ongoing HIV replication, it was hoped that they would also be spared from the enormous chronic inflammation that typically accompanied those infections,' she said. Chronic inflammation that persists over years is a powerful driver of cardiovascular disease (CVD), which leads to premature strokes and heart attacks in adulthood, she emphasized. The researchers reviewed data from 185 individuals aged 7-16 years who were part of a study of early ART in South Africa. The study population included 65 CHIV and 118 HIV-unexposed children who served as control individuals. The CHIV began ART within 3 months of birth and were deemed clinically well at the time of blood testing for biomarkers. The participants underwent a median of two measures of blood serum 4 years apart, yielding a total of 321 observations; 26 biomarkers were measured. After adjusting for multiple variables, the CHIV group had significantly higher levels of C-reactive protein, soluble CD14 (a marker of monocyte activation), and vascular endothelial growth factor than the unexposed children. The researchers also found specific effects in different age groups. Levels of Monocyte chemoattractant protein-1 (MCP-1), interleukin 6, and P-selectin in CHIV aged 6-8 years were significantly higher than matched control individuals, whereas MCP-1 was significantly higher in the CHIV group aged 13-16 years than control individuals. No other significant differences in biomarkers appeared between the groups. When the current study began, it was entirely unknown whether early-treated children living with HIV would suffer from the same chronic inflammation and consequent premature CVD, or to what extent early lifelong ART might prevent CVD in these children as they grew, Davies told Medscape Medical News . 'We hoped that by removing ongoing HIV replication and opportunistic infections, children living with HIV would be spared from the chronic inflammation that drives premature CVD in early adulthood,' she said. The researchers had hoped to find that early ART had a greater impact on preventing chronic inflammation, but the results showed otherwise, said Davies. The data should alert clinicians to the increased risk for premature strokes and heart attacks in adulthood for children treated early with ART, she said. For the study population treated with ART, their chronic inflammation can no longer be a result of ongoing HIV replication and opportunistic infections because these factors are no longer present, Davies told Medscape Medical News . 'We now need to understand what is driving their ongoing chronic inflammation so that we can find treatments to help reduce it, and in so doing, reduce their risk of premature strokes and heart attacks in adulthood,' she said. ART Alone is Not Enough 'While early ART dramatically improves long-term outcomes for children born with perinatal HIV, it remains unclear whether early ART alters the long-term inflammatory and immune activation profile,' said Jason E. Zucker, MD, an assistant professor of medicine and infectious diseases specialist at Columbia University Irving Medical Center, New York City, in an interview. 'These profiles are critical, as they are linked to future risk of noncommunicable diseases, such as cardiovascular and metabolic disorders,' said Zucker, who was not involved in the study. The current study fills a key gap by examining longitudinal biomarker data to assess persistent immune dysregulation in early treated children compared with uninfected control individuals, he said. Zucker said he was slightly surprised by the findings of extensive immune activation and elevated biomarkers, into adolescence, especially those associated with monocyte activation. 'The key takeaway is that early ART alone may not fully normalize immune activation in perinatally HIV-infected children,' he said. 'The data underscore the need for long-term monitoring and potentially adjunctive interventions to mitigate inflammation and reduce future disease risk, even among virologically suppressed youth,' he added. Some limitations of the study include the modest sample size and lack of any long-term clinical outcomes, Zucker told Medscape Medical News . 'Biomarker assessments, while robust, do not confirm clinical endpoints such as actual cardiovascular events, and future research should track these cohorts longitudinally into adulthood to determine whether the observed immune profiles translate into actual disease, and explore therapeutic strategies,' he said.
Yahoo
a day ago
- Yahoo
Want a glass of wine with dinner? Blame our ape ancestors
Craving a glass of wine with your dinner? The dietary habits of our ape ancestors may be to blame. To better understand the relationship between humans and alcohol, researchers are studying the animals' fondness for fermented and fallen fruit, newly referred to as 'scrumping.' "Scrumping by the last common ancestor of gorillas, chimpanzees, and humans about 10 million years ago could explain why humans are so astoundingly good at digesting alcohol," Nathaniel Dominy, the Charles Hansen Professor of Anthropology at Dartmouth College, said in a statement. "We evolved to metabolize alcohol long before we ever figured out how to make it, and making it was one of the major drivers of the Neolithic Revolution that turned us from hunter-gatherers into farmers and changed the world,' he added. Fermentation is the process by which bacteria and other microorganisms break down sugars into substances such as alcohols or acids. All of the alcohol we drink is made this way. When you drink alcohol, you get drunk because you're consuming faster than your metabolism can handle. In apes, researchers said this doesn't seem to be the case. Geneticists previously reported that eating fermented fruit may have led to a biological change in the last common ancestor of humans and African apes that boosted their ability to metabolize alcohol by 40 times. However, no one had the data to test it, and scientists had not differentiated fruit in the trees from that on the ground when studying the primates since then. "It just wasn't on our radar," Dominy explained. "It's not that primatologists have never seen scrumping — they observe it pretty regularly. But the absence of a word for it has disguised its importance.' The team wanted to know what significance scrumping had for human evolution so analyzed previous research on dietary habits of orangutans, chimpanzees, and mountain and western gorillas in the wild. The studies included thousands of scans of the primates eating fruit. If an ape at ground level was recorded eating fruit known to grow in the middle or upper levels of the forest canopy, it was counted as scrumping. Of the three species, African apes were found to 'scrump' regularly, while orangutans did not. To better understand chimpanzees' alcohol consumption, the researchers will next measure the levels of fermentation in fruits in trees, versus that on the ground. The researchers said their findings confirm results of past research which had also found that the primary enzyme for metabolizing ethanol — found in alcoholic beverages — is relatively inefficient in orangutans and other non-human primates. The researchers believe that the African apes' ability to metabolize ethanol may let them safely consume a whopping 10 pounds of fruit each day. That level of intake suggests exposure to ethanol could be a significant component of chimpanzee life, and a major force of human evolution. Humans may have retained the social aspects that apes bring to scrumping, Catherine Hobaiter, a professor of psychology and neuroscience at St Andrews, said. "A fundamental feature of our relationship with alcohol is our tendency to drink together, whether a pint with friends or a large social feast," she added. "The next step is to investigate how shared feeding on fermented fruits might also influence social relationships in other apes." Solve the daily Crossword
